Giedrius Zunda served as the CEO of Northway Biotech, a biologics CDMO and as an Executive Consultant in Wellgem Biopharma, a consulting company for biopharma, prior to joining Alvotech. He also directed Teva Baltics’ biologics development and manufacturing site in Lithuania. Giedrius has been responsible for biologics/biosimilars molecule manufacturing and successful approval by European and US regulatory agencies, completing FDA PAI/GMP inspections and supporting product launches. He has also managed expanding operations internationally, product portfolio additions and diversification, as well as establishment of new facilities for biologics development and manufacturing.
Giedrius holds an MS degree in biotechnology from the Vilnius Gediminas Technical University and EMBA from the Baltic Management Institute, Lithuania.